Cardiff Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.About CRDF
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
CRDF Key Statistics
Stock Snapshot
With a market cap of 76.97M, Cardiff Oncology(CRDF) trades at $0.99. The stock has a price-to-earnings ratio of -1.67.
On 2026-08-14, Cardiff Oncology(CRDF) stock moved within a range of $0.96 to $1.02. With shares now at $0.99, the stock is trading +2.6% above its intraday low and -3.4% below the session's peak.
Trading activity shows a volume of 235.94K, compared to an average daily volume of 797.95K.
Over the past 52 weeks, Cardiff Oncology(CRDF) stock has traded between a high of $3.31 and a low of $0.76.
Over the past 52 weeks, Cardiff Oncology(CRDF) stock has traded between a high of $3.31 and a low of $0.76.
Analyst ratings
63%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.